Ligand Pharma Updates Annual Guidance As It Spins Out Pelica

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) entered into a merger agreement under which its subsidiary, Pelican Technology Holdings Inc, has become a wholly owned subsidiary of Primrose Bio Inc. 

Related Keywords

Primrose Bio , Alvogen Teriparatide , Serum Institute Of India Pneumosil , Pelican Expression Technology , Ligand Pharmaceuticals Incorporated , Primrose Bio Inc , Pelican Technology Holdings Inc , Sale Agreement , Primordial Genetics , Serum Institute ,